$CWBHF
Stock $cwbhf

$cwbhf Overview Financials Valuation SEC Filings Company Website

2021 Q4 Form 10-K Financial Statement

#000175015522000041 Filed on March 24, 2022

Income Statement

Concept	2021 Q4	2021	2020 Q4
Revenue	$24.83M	$96.09M	$26.93M
YoY Change	-7.8%	0.91%	17.96%
Cost Of Revenue	$20.62M	$47.51M	$16.16M
YoY Change	27.62%	10.64%	-32.95%
Gross Profit	$4.206M	$48.59M	$10.77M
YoY Change	-60.95%	-7.08%	-948.03%
Gross Profit Margin	16.94%	50.56%	39.99%
Selling, General & Admin	$24.38M	$97.64M	$17.24M
YoY Change	41.4%	-5.78%	-10.07%
% of Gross Profit	579.6%	200.97%	160.07%
Research & Development		$5.502M	$1.670M
YoY Change		-7.54%	153.03%
% of Gross Profit		11.32%	15.51%
Depreciation & Amortization	$2.797M	$11.03M	$3.030M
YoY Change	-7.69%	61.02%	108.97%
% of Gross Profit	66.5%	22.69%	28.13%
Operating Expenses	$24.38M	$103.1M	$23.61M
YoY Change	3.25%	-5.88%	-10.43%
Operating Profit	-$20.17M	-$147.1M	-$12.84M
YoY Change	57.1%	186.43%	-53.53%
Interest Expense	$347.0K	$9.429M	-$350.0K
YoY Change	-199.14%	-973.06%	-683.33%
% of Operating Profit
Other Income/Expense, Net	-$269.0K	$51.00K	-$1.720M
YoY Change	-84.36%	-96.17%	-159.93%
Pretax Income	-$118.1M	-$137.6M	-$14.73M
YoY Change	701.74%	255.55%	-42.24%
Income Tax	$151.0K	$143.0K	-$10.00K
% Of Pretax Income
Net Earnings	-$118.2M	-$137.7M	-$14.72M
YoY Change	703.32%	348.88%	-21.62%
Net Earnings / Revenue	-476.25%	-143.32%	-54.66%
Basic Earnings Per Share		-$0.98
Diluted Earnings Per Share	-$840.0K	-$0.98	-$105.6K
COMMON SHARES
Basic Shares Outstanding		140.8M shares
Diluted Shares Outstanding		140.8M shares

Balance Sheet

Concept	2021 Q4	2021	2020 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$19.49M	$19.49M	$52.80M
YoY Change	-63.08%	-63.08%	-23.03%
Cash & Equivalents	$19.49M	$19.49M	$52.80M
Short-Term Investments
Other Short-Term Assets	$8.095M	$8.095M	$7.400M
YoY Change	9.39%	9.39%	105.56%
Inventory	$52.08M	$52.08M	$63.16M
Prepaid Expenses	$6.224M		$4.621M
Receivables	$4.882M	$4.882M	$4.793M
Other Receivables	$946.0K	$11.26M	$1.482M
Total Short-Term Assets	$95.81M	$95.81M	$143.8M
YoY Change	-33.37%	-32.81%	-1.78%
LONG-TERM ASSETS
Property, Plant & Equipment	$36.09M	$56.76M	$39.36M
YoY Change	-8.33%	-5.86%	-8.24%
Goodwill	$0.00		$76.04M
YoY Change	-100.0%
Intangibles	$2.843M		$25.38M
YoY Change	-88.8%
Long-Term Investments
YoY Change
Other Assets	$2.062M	$15.06M	$5.177M
YoY Change	-60.17%	189.65%	-83.82%
Total Long-Term Assets	$75.71M	$75.71M	$167.0M
YoY Change	-54.66%	-55.02%	118.29%
TOTAL ASSETS
Total Short-Term Assets	$95.81M	$95.81M	$143.8M
Total Long-Term Assets	$75.71M	$75.71M	$167.0M
Total Assets	$171.5M	$171.5M	$310.8M
YoY Change	-44.81%	-44.83%	39.43%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$5.049M	$5.049M	$4.891M
YoY Change	3.23%	3.04%	-44.42%
Accrued Expenses	$9.570M	$9.570M	$12.76M
YoY Change	-25.02%	-16.78%	74.84%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$5.551M	$5.551M	$11.90M
YoY Change	-53.35%	-53.35%	-7.03%
Total Short-Term Liabilities	$20.17M	$20.17M	$28.87M
YoY Change	-30.14%	-30.45%	-1.79%
LONG-TERM LIABILITIES
Long-Term Debt	$20.89M	$20.89M	$23.20M
YoY Change	-9.98%	-9.98%	4.98%
Other Long-Term Liabilities	$12.00K	$12.00K	$4.500M
YoY Change	-99.73%	-99.73%	-74.58%
Total Long-Term Liabilities	$12.00K	$20.90M	$27.70M
YoY Change	-99.96%	-24.56%	-30.4%
TOTAL LIABILITIES
Total Short-Term Liabilities	$20.17M	$20.17M	$28.87M
Total Long-Term Liabilities	$12.00K	$20.90M	$27.70M
Total Liabilities	$41.07M	$41.07M	$56.55M
YoY Change	-27.37%	-27.57%	-18.29%
SHAREHOLDERS EQUITY
Retained Earnings	-$188.6M		-$50.89M
YoY Change	270.62%
Common Stock	$1.000K		$1.000K
YoY Change	0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$130.4M	$130.4M	$254.2M
YoY Change
Total Liabilities & Shareholders Equity	$171.5M	$171.5M	$310.8M
YoY Change	-44.81%	-44.83%	39.43%

Cashflow Statement

Concept	2021 Q4	2021	2020 Q4
OPERATING ACTIVITIES
Net Income	-$118.2M	-$137.7M	-$14.72M
YoY Change	703.32%	348.88%	-21.62%
Depreciation, Depletion And Amortization	$2.797M	$11.03M	$3.030M
YoY Change	-7.69%	61.02%	108.97%
Cash From Operating Activities	-$6.235M	-$29.56M	-$5.040M
YoY Change	23.71%	-43.19%	-42.0%
INVESTING ACTIVITIES
Capital Expenditures	-$830.0K	-$4.918M	-$5.920M
YoY Change	-85.98%	-82.6%	39.62%
Acquisitions
YoY Change
Other Investing Activities	$131.0K	-$606.0K	-$1.660M
YoY Change	-107.89%	-167.56%	176.67%
Cash From Investing Activities	-$699.0K	-$11.79M	-$7.580M
YoY Change	-90.78%	-38.46%	55.97%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net		$8.257M
YoY Change		-84.65%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	5.359M	$8.039M	-470.0K
YoY Change	-1240.21%	-85.5%	-101.0%
NET CHANGE
Cash From Operating Activities	-6.235M	-$29.56M	-5.040M
Cash From Investing Activities	-699.0K	-$11.79M	-7.580M
Cash From Financing Activities	5.359M	$8.039M	-470.0K
Net Change In Cash	-1.575M	-$33.31M	-13.09M
YoY Change	-87.97%	111.49%	-139.0%
FREE CASH FLOW
Cash From Operating Activities	-$6.235M	-$29.56M	-$5.040M
Capital Expenditures	-$830.0K	-$4.918M	-$5.920M
Free Cash Flow	-$5.405M	-$24.64M	$880.0K
YoY Change	-714.2%	3.67%	-119.78%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2021	dei	Amendment Flag AmendmentFlag	false
CY2021	dei	Entity Central Index Key EntityCentralIndexKey	0001750155
CY2021	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2021
CY2021	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2021	cweb	Common Stock Conversion Ratio CommonStockConversionRatio	0.0025
CY2020Q2	cweb	Number Of Warrants In Each Unit NumberOfWarrantsInEachUnit	0.5	shares
CY2019Q4	cweb	Number Of Warrants In Each Unit NumberOfWarrantsInEachUnit	0.5	shares
CY2021	dei	Document Type DocumentType	10-K
CY2021	dei	Document Annual Report DocumentAnnualReport	true
CY2021	dei	Document Period End Date DocumentPeriodEndDate	2021-12-31
CY2021	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2021	dei	Document Transition Report DocumentTransitionReport	false
CY2021	dei	Entity File Number EntityFileNumber	000-56364
CY2021	dei	Entity Registrant Name EntityRegistrantName	Charlotte's Web Holdings, Inc.
CY2021	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	A1
CY2021	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	98-1508633
CY2021	dei	Entity Address Address Line1 EntityAddressAddressLine1	1801 California Street
CY2021	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 4800
CY2021	dei	Entity Address City Or Town EntityAddressCityOrTown	Denver
CY2021	dei	Entity Address State Or Province EntityAddressStateOrProvince	CO
CY2021	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	80202
CY2021	dei	City Area Code CityAreaCode	720
CY2021	dei	Local Phone Number LocalPhoneNumber	617-7303
CY2021	dei	Security12g Title Security12gTitle	Common stock, no par value
CY2021	dei	Entity Current Reporting Status EntityCurrentReportingStatus	No
CY2021	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2021	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2021	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2021	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2021	dei	Entity Small Business EntitySmallBusiness	true
CY2021	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2021	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
CY2021	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2021	dei	Entity Shell Company EntityShellCompany	false
CY2021Q2	dei	Entity Public Float EntityPublicFloat	499600000	USD
CY2022Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	145110106	shares
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	20170000	USD
CY2020Q4	us-gaap	Liabilities Current LiabilitiesCurrent	28874000	USD
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	19494000	USD
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	52803000	USD
CY2020Q4	us-gaap	Assets Current AssetsCurrent	143795000	USD
CY2021	dei	Auditor Firm AuditorFirmId	42
CY2021	dei	Auditor Name AuditorName	Ernst & Young LLP
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	19494000	USD
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	52803000	USD
CY2021	dei	Auditor Location AuditorLocation	Denver, Colorado
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	19494000	USD
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	52803000	USD
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	4882000	USD
CY2020Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	4793000	USD
CY2021Q4	us-gaap	Notes And Loans Receivable Net Current NotesAndLoansReceivableNetCurrent	495000	USD
CY2020Q4	us-gaap	Notes And Loans Receivable Net Current NotesAndLoansReceivableNetCurrent	2757000	USD
CY2021Q4	us-gaap	Inventory Net InventoryNet	52077000	USD
CY2020Q4	us-gaap	Inventory Net InventoryNet	63157000	USD
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	8095000	USD
CY2020Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	8845000	USD
CY2021Q4	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	10764000	USD
CY2020Q4	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	11440000	USD
CY2021Q4	us-gaap	Assets Current AssetsCurrent	95807000	USD
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	36085000	USD
CY2020Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	39363000	USD
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	20679000	USD
CY2020Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	21037000	USD
CY2021Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	2843000	USD
CY2020Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	25376000	USD
CY2021Q4	us-gaap	Goodwill Goodwill	0	USD
CY2020Q4	us-gaap	Goodwill Goodwill	76039000	USD
CY2021Q4	cweb	Business Combination Purchase Option BusinessCombinationPurchaseOption	13000000	USD
CY2020Q4	cweb	Business Combination Purchase Option BusinessCombinationPurchaseOption	0	USD
CY2021Q4	us-gaap	Notes And Loans Receivable Net Noncurrent NotesAndLoansReceivableNetNoncurrent	1037000	USD
CY2020Q4	us-gaap	Notes And Loans Receivable Net Noncurrent NotesAndLoansReceivableNetNoncurrent	0	USD
CY2021Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	2062000	USD
CY2020Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	5177000	USD
CY2021Q4	us-gaap	Assets Assets	171513000	USD
CY2020Q4	us-gaap	Assets Assets	310787000	USD
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	5049000	USD
CY2020Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	4891000	USD
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	9570000	USD
CY2020Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	12763000	USD
CY2021Q4	cweb	Cultivation Liabilities Current CultivationLiabilitiesCurrent	3448000	USD
CY2020Q4	cweb	Cultivation Liabilities Current CultivationLiabilitiesCurrent	9304000	USD
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	2103000	USD
CY2020Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1916000	USD
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	20170000	USD
CY2020Q4	us-gaap	Liabilities Current LiabilitiesCurrent	28874000	USD
CY2021Q4	cweb	Cultivation Liabilities Noncurrent CultivationLiabilitiesNoncurrent	385000	USD
CY2020Q4	cweb	Cultivation Liabilities Noncurrent CultivationLiabilitiesNoncurrent	2513000	USD
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	20500000	USD
CY2020Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	20567000	USD
CY2021Q4	cweb	Warrants And Rights Outstanding And Other Liabilities Noncurrent WarrantsAndRightsOutstandingAndOtherLiabilitiesNoncurrent	12000	USD
CY2020Q4	cweb	Warrants And Rights Outstanding And Other Liabilities Noncurrent WarrantsAndRightsOutstandingAndOtherLiabilitiesNoncurrent	4591000	USD
CY2021Q4	us-gaap	Liabilities Liabilities	41067000	USD
CY2020Q4	us-gaap	Liabilities Liabilities	56545000	USD
CY2021Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2020Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	144659964	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	144659964	shares
CY2020Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	107060237	shares
CY2020Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	107060237	shares
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	1000	USD
CY2020Q4	us-gaap	Common Stock Value CommonStockValue	1000	USD
CY2020Q4	cweb	Proportionate Voting Stock Shares Issued ProportionateVotingStockSharesIssued	81177	shares
CY2020Q4	cweb	Proportionate Voting Stock Shares Outstanding ProportionateVotingStockSharesOutstanding	81177	shares
CY2021Q4	cweb	Proportionate Voting Stock Value Issued ProportionateVotingStockValueIssued	0	USD
CY2020Q4	cweb	Proportionate Voting Stock Value Issued ProportionateVotingStockValueIssued	0	USD
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	319059000	USD
CY2020Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	305133000	USD
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-188614000	USD
CY2020Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-50892000	USD
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	130446000	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	254242000	USD
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	171513000	USD
CY2020Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	310787000	USD
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	96092000	USD
CY2020	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	95226000	USD
CY2021	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	47507000	USD
CY2020	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	42937000	USD
CY2021	us-gaap	Gross Profit GrossProfit	48585000	USD
CY2020	us-gaap	Gross Profit GrossProfit	52289000	USD
CY2021	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	97641000	USD
CY2020	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	103631000	USD
CY2021	us-gaap	Asset Impairment Charges AssetImpairmentCharges	98003000	USD
CY2020	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0	USD
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	-147059000	USD
CY2020	us-gaap	Operating Income Loss OperatingIncomeLoss	-51342000	USD
CY2021	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	51000	USD
CY2020	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	1330000	USD
CY2021	cweb	Change In Fair Value Of Financial Instruments And Other Gain Loss ChangeInFairValueOfFinancialInstrumentsAndOtherGainLoss	9429000	USD
CY2020	cweb	Change In Fair Value Of Financial Instruments And Other Gain Loss ChangeInFairValueOfFinancialInstrumentsAndOtherGainLoss	11317000	USD
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-137579000	USD
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-38695000	USD
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	143000	USD
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-8014000	USD
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-137722000	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-30681000	USD
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.98
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.98
CY2020	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.25
CY2020	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.25
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	140769247	shares
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	140769247	shares
CY2020	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	125012249	shares
CY2020	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	125012249	shares
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	123996000	USD
CY2020	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	2467000	USD
CY2020	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	19000	USD
CY2020	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	3149000	USD
CY2020	cweb	Stock Issued During Period Value Asset Acquisition StockIssuedDuringPeriodValueAssetAcquisition	1177000	USD
CY2020	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	44591000	USD
CY2020	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	109562000	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-30681000	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	254242000	USD
CY2021	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	30000	USD
CY2021	cweb	Stock Issued During Period Value Exercise Of Warrants StockIssuedDuringPeriodValueExerciseOfWarrants	441000	USD
CY2021	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	146000	USD
CY2021	cweb	Stock Issued During Period Value Asset Acquisition StockIssuedDuringPeriodValueAssetAcquisition	1460000	USD
CY2021	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	8118000	USD
CY2021	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	4023000	USD
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-137722000	USD
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	130446000	USD
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-137722000	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-30681000	USD
CY2021	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	11025000	USD
CY2020	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	6847000	USD
CY2021	us-gaap	Asset Impairment Charges AssetImpairmentCharges	98003000	USD
CY2020	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0	USD
CY2021	cweb	Change In Fair Value Of Financial Instruments Gain Loss ChangeInFairValueOfFinancialInstrumentsGainLoss	9305000	USD
CY2020	cweb	Change In Fair Value Of Financial Instruments Gain Loss ChangeInFairValueOfFinancialInstrumentsGainLoss	11167000	USD
CY2021	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	1509000	USD
CY2020	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	834000	USD
CY2021	us-gaap	Inventory Write Down InventoryWriteDown	9729000	USD
CY2020	us-gaap	Inventory Write Down InventoryWriteDown	8025000	USD
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	5483000	USD
CY2020	us-gaap	Share Based Compensation ShareBasedCompensation	4326000	USD
CY2021	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	-390000	USD
CY2020	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	5000	USD
CY2021	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	948000	USD
CY2020	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-1470000	USD
CY2021	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-1023000	USD
CY2020	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	1782000	USD
CY2021	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-694000	USD
CY2020	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	2867000	USD
CY2021	cweb	Increase Decrease In Operating Lease Right Of Use Assets And Operating Lease Liability IncreaseDecreaseInOperatingLeaseRightOfUseAssetsAndOperatingLeaseLiability	-138000	USD
CY2020	cweb	Increase Decrease In Operating Lease Right Of Use Assets And Operating Lease Liability IncreaseDecreaseInOperatingLeaseRightOfUseAssetsAndOperatingLeaseLiability	-569000	USD
CY2021	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-2911000	USD
CY2020	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-8075000	USD
CY2021	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	676000	USD
CY2020	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	-8133000	USD
CY2021	cweb	Increase Decrease In Cultivation Liabilities IncreaseDecreaseInCultivationLiabilities	-7166000	USD
CY2020	cweb	Increase Decrease In Cultivation Liabilities IncreaseDecreaseInCultivationLiabilities	-11289000	USD
CY2021	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	177000	USD
CY2020	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	101000	USD
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-29559000	USD
CY2020	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-52029000	USD
CY2021	us-gaap	Cash Acquired From Acquisition CashAcquiredFromAcquisition	0	USD
CY2020	us-gaap	Cash Acquired From Acquisition CashAcquiredFromAcquisition	11181000	USD
CY2021	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	4918000	USD
CY2020	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	28257000	USD
CY2021	us-gaap	Proceeds From Sale Of Productive Assets ProceedsFromSaleOfProductiveAssets	13000	USD
CY2020	us-gaap	Proceeds From Sale Of Productive Assets ProceedsFromSaleOfProductiveAssets	91000	USD
CY2021	cweb	Payments To Acquire Notes Receivable Net Of Proceeds From Collection PaymentsToAcquireNotesReceivableNetOfProceedsFromCollection	510000	USD
CY2020	cweb	Payments To Acquire Notes Receivable Net Of Proceeds From Collection PaymentsToAcquireNotesReceivableNetOfProceedsFromCollection	-1275000	USD
CY2021	cweb	Payment For Business Combination Purchase Option PaymentForBusinessCombinationPurchaseOption	8000000	USD
CY2020	cweb	Payment For Business Combination Purchase Option PaymentForBusinessCombinationPurchaseOption	0	USD
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	19494000	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	52803000	USD
CY2021	us-gaap	Business Combination Consideration Transferred Equity Interests Issued And Issuable BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable	0	USD
CY2021	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	-606000	USD
CY2020	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	897000	USD
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-11789000	USD
CY2020	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-19157000	USD
CY2021	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	8257000	USD
CY2020	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	53797000	USD
CY2021	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	30000	USD
CY2020	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	2467000	USD
CY2021	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-248000	USD
CY2020	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-828000	USD
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	8039000	USD
CY2020	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	55436000	USD
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-33309000	USD
CY2020	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-15750000	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	52803000	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	68553000	USD
CY2020	us-gaap	Business Combination Consideration Transferred Equity Interests Issued And Issuable BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable	109562000	USD
CY2021	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	2500000	USD
CY2020	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	1291000	USD
CY2021	cweb	Reduction To Cultivation Liabilities For Inventory Provision ReductionToCultivationLiabilitiesForInventoryProvision	543000	USD
CY2020	cweb	Reduction To Cultivation Liabilities For Inventory Provision ReductionToCultivationLiabilitiesForInventoryProvision	2073000	USD
CY2021	us-gaap	Use Of Estimates UseOfEstimates	<div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates </span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with U.S. GAAP requires management to make informed estimates, judgments and assumptions that may affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements, the reported amounts of revenues and expenses during the reporting period and the disclosures in the accompanying notes. On an ongoing basis, management evaluates such estimates and assumptions for continued reasonableness. In particular, management makes estimates with respect to any (i) inventory provision, (ii) underlying assumptions that affect the potential impairment of goodwill and long-lived assets, (iii) </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ability to realize income tax benefits associated with deferred tax assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, (iv) fair value of acquired intangible assets and goodwill, and (v) underlying assumptions that affect the fair value of the SBH Purchase Option. Appropriate adjustments, if any, to the estimates used are made prospectively based upon such periodic evaluation. Management’s estimates are based on historical information available at the date of the consolidated financial statements and various other assumptions management believes are reasonable based on the circumstances. Actual results could differ materially from those estimates.</span></div>
CY2021	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Reclassifications and prior period presentations</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain amounts presented in prior periods have been reclassified to conform with the current period presentation.</span></div>
CY2021	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	segment
CY2021	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Concentration of Credit Risk</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial instruments that potentially subject the Company to concentrations of credit risk consist primarily of cash and cash equivalents and accounts receivable. The cash amounts in deposit accounts held in excess of federally-insured limits were $19,244 and $52,516 as of December 31, 2021 and 2020, respectively. Management believes that the Company is not exposed to significant credit risk due to the financial strength of the depository institution in which the cash is held.</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company provides credit to its customers in the normal course of business and has established credit evaluation and monitoring processes to mitigate credit risk, but has limited risk, as the majority of its sales are transacted with cash.</span></div>As of December 31, 2021 and 2020, no single customer accounted for more than 10% of the Company’s consolidated revenue. As of December 31, 2021 the Company had one customer whose accounts receivable balance individually represented 34% of the Company's accounts receivable. At December 31, 2020, no single customer accounted for more than 10% of the Company's accounts receivable.
CY2021Q4	us-gaap	Cash Uninsured Amount CashUninsuredAmount	19244000	USD
CY2020Q4	us-gaap	Cash Uninsured Amount CashUninsuredAmount	52516000	USD
CY2021Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	6224000	USD
CY2020Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	4621000	USD
CY2021Q4	us-gaap	Deposits Assets Current DepositsAssetsCurrent	925000	USD
CY2020Q4	us-gaap	Deposits Assets Current DepositsAssetsCurrent	2742000	USD
CY2021Q4	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	946000	USD
CY2020Q4	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	1482000	USD
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	8095000	USD
CY2020Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	8845000	USD
CY2020	us-gaap	Advertising Expense AdvertisingExpense	14723000	USD
CY2021	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	5502000	USD
CY2020	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	5951000	USD
CY2021	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	441000	USD
CY2020	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	1038000	USD
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	96092000	USD
CY2020	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	95226000	USD
CY2021	us-gaap	Advertising Expense AdvertisingExpense	17523000	USD
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
CY2021Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	179000	USD
CY2020Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	134000	USD
CY2021Q4	cweb	Business Combination Purchase Option BusinessCombinationPurchaseOption	13000000	USD
CY2021Q4	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	0	USD
CY2020Q4	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	0	USD
CY2020Q4	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	4304000	USD
CY2021Q1	cweb	Payment For Business Combination Purchase Option PaymentForBusinessCombinationPurchaseOption	8000	USD
CY2021Q1	cweb	Business Combination Purchase Option Term BusinessCombinationPurchaseOptionTerm	P5Y
CY2021Q1	cweb	Business Combination Purchase Option Extension Term BusinessCombinationPurchaseOptionExtensionTerm	P2Y
CY2021Q1	cweb	C Class Of Warrant Or Right Percentage Of Outstanding Shares CClassOfWarrantOrRightPercentageOfOutstandingShares	0.10
CY2021Q1	us-gaap	Warrants And Rights Outstanding Term WarrantsAndRightsOutstandingTerm	P60D
CY2021	cweb	Gain Loss On Fair Value Adjustment Business Combination Purchase Option GainLossOnFairValueAdjustmentBusinessCombinationPurchaseOption	5000	USD
CY2021Q4	cweb	Business Combination Purchase Option BusinessCombinationPurchaseOption	13000000	USD
CY2021	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-4304000	USD
CY2020	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-11167000	USD
CY2021Q4	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	0	USD
CY2021Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	38249000	USD
CY2020Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	41090000	USD
CY2021Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	15189000	USD
CY2021Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	47321000	USD
CY2020Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	14644000	USD
CY2021Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	13974000	USD
CY2020Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	24615000	USD
CY2021Q4	us-gaap	Inventory Gross InventoryGross	67412000	USD
CY2020Q4	us-gaap	Inventory Gross InventoryGross	80349000	USD
CY2021Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	15335000	USD
CY2020Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	17192000	USD
CY2021Q4	us-gaap	Inventory Net InventoryNet	52077000	USD
CY2020Q4	us-gaap	Inventory Net InventoryNet	63157000	USD
CY2021	cweb	Inventory Provisions InventoryProvisions	10272000	USD
CY2021	us-gaap	Inventory Write Down InventoryWriteDown	9729000	USD
CY2021	cweb	Inventory Provisions Settlement Reduction Of Cultivation Liabilities InventoryProvisionsSettlementReductionOfCultivationLiabilities	543000	USD
CY2021	us-gaap	Production Related Impairments Or Charges ProductionRelatedImpairmentsOrCharges	12129000	USD
CY2020	us-gaap	Inventory Write Down InventoryWriteDown	8025000	USD
CY2020	cweb	Inventory Provisions Settlement Reduction Of Cultivation Liabilities InventoryProvisionsSettlementReductionOfCultivationLiabilities	2073000	USD
CY2020	us-gaap	Production Related Impairments Or Charges ProductionRelatedImpairmentsOrCharges	8779000	USD
CY2020Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	43811000	USD
CY2020	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	USD
CY2021Q4	us-gaap	Goodwill Goodwill	0	USD
CY2020Q4	us-gaap	Goodwill Goodwill	76039000	USD
CY2021Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	13829000	USD
CY2020Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	10551000	USD
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	36085000	USD
CY2020Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	39363000	USD
CY2021	us-gaap	Depreciation Depreciation	7481000	USD
CY2020	us-gaap	Depreciation Depreciation	4839000	USD
CY2021	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	1921000	USD
CY2020Q4	us-gaap	Goodwill Goodwill	76039000	USD
CY2019Q4	us-gaap	Goodwill Goodwill	0	USD
CY2021	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	0	USD
CY2020Q4	us-gaap	Goodwill Goodwill	76039000	USD
CY2021	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	76039000	USD
CY2021	us-gaap	Number Of Reporting Units NumberOfReportingUnits	1	reporting_unit
CY2021	us-gaap	Number Of Reporting Units NumberOfReportingUnits	1	reporting_unit
CY2021	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	76039000	USD
CY2021Q4	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	150000	USD
CY2021Q4	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	150000	USD
CY2021Q4	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	5209000	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	2366000	USD
CY2021Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	2843000	USD
CY2021	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	19750000	USD
CY2020Q4	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	150000	USD
CY2020Q4	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	150000	USD
CY2020Q4	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	27848000	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	2472000	USD
CY2020Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	25376000	USD
CY2021	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	3544000	USD
CY2020	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	2008000	USD
CY2021	us-gaap	Variable Lease Cost VariableLeaseCost	1512000	USD
CY2021Q1	us-gaap	Line Of Credit Facility Maximum Borrowing Capacity LineOfCreditFacilityMaximumBorrowingCapacity	10000000000	USD
CY2021Q1	cweb	Line Of Credit Facility Accordion Feature LineOfCreditFacilityAccordionFeature	20000000000	USD
CY2021Q4	us-gaap	Lessee Operating Lease Renewal Term LesseeOperatingLeaseRenewalTerm	P5Y
CY2021Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P10Y4M13D
CY2021Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0543
CY2021	us-gaap	Operating Lease Cost OperatingLeaseCost	2969000	USD
CY2020	us-gaap	Operating Lease Cost OperatingLeaseCost	4014000	USD
CY2020	us-gaap	Variable Lease Cost VariableLeaseCost	1707000	USD
CY2021	cweb	Lease Cost Excluding Sublease Income LeaseCostExcludingSubleaseIncome	4481000	USD
CY2020	cweb	Lease Cost Excluding Sublease Income LeaseCostExcludingSubleaseIncome	5721000	USD
CY2021	us-gaap	Sublease Income SubleaseIncome	724000	USD
CY2020	us-gaap	Sublease Income SubleaseIncome	478000	USD
CY2021	us-gaap	Operating Lease Payments OperatingLeasePayments	3528000	USD
CY2020	us-gaap	Operating Lease Payments OperatingLeasePayments	3153000	USD
CY2021	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	2350000	USD
CY2020	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	515000	USD
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	3331000	USD
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	3410000	USD
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	3255000	USD
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	2946000	USD
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	2222000	USD
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	15595000	USD
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	30759000	USD
CY2021Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	8156000	USD
CY2021Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	22603000	USD
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	2103000	USD
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	20500000	USD
CY2021	cweb	Cultivation Settlement Reduction CultivationSettlementReduction	855000	USD
CY2020	cweb	Cultivation Liability Settlement Reduction Current CultivationLiabilitySettlementReductionCurrent	2073000	USD
CY2019Q4	cweb	Cultivation Liabilities Current CultivationLiabilitiesCurrent	10803000	USD
CY2019Q4	cweb	Cultivation Liabilities Noncurrent CultivationLiabilitiesNoncurrent	14289000	USD
CY2019Q4	cweb	Cultivation Liabilities CultivationLiabilities	25092000	USD
CY2020	cweb	Cultivation Liability Settlement Payments Current CultivationLiabilitySettlementPaymentsCurrent	11289000	USD
CY2020	cweb	Cultivation Liability Settlement Payments Noncurrent CultivationLiabilitySettlementPaymentsNoncurrent	0	USD
CY2020	cweb	Cultivation Liability Settlement Payments CultivationLiabilitySettlementPayments	11289000	USD
CY2020	cweb	Cultivation Liability Settlement Reduction Current CultivationLiabilitySettlementReductionCurrent	2073000	USD
CY2020	cweb	Cultivation Liability Settlement Reduction Noncurrent CultivationLiabilitySettlementReductionNoncurrent	0	USD
CY2020	cweb	Cultivation Liability Settlement Reduction CultivationLiabilitySettlementReduction	2073000	USD
CY2020	cweb	Cultivation Liability Interest Expense Current CultivationLiabilityInterestExpenseCurrent	87000	USD
CY2020	cweb	Cultivation Liability Interest Expense Noncurrent CultivationLiabilityInterestExpenseNoncurrent	0	USD
CY2020	cweb	Cultivation Liability Interest Expense CultivationLiabilityInterestExpense	87000	USD
CY2020	cweb	Cultivation Liability Conversion To Short Term Borrowing Current CultivationLiabilityConversionToShortTermBorrowingCurrent	-11776000	USD
CY2020	cweb	Cultivation Liability Conversion To Short Term Borrowing Noncurrent CultivationLiabilityConversionToShortTermBorrowingNoncurrent	11776000	USD
CY2020	cweb	Cultivation Liability Conversion To Short Term Borrowing CultivationLiabilityConversionToShortTermBorrowing	0	USD
CY2020Q4	cweb	Cultivation Liabilities Current CultivationLiabilitiesCurrent	9304000	USD
CY2020Q4	cweb	Cultivation Liabilities Noncurrent CultivationLiabilitiesNoncurrent	2513000	USD
CY2020Q4	cweb	Cultivation Liabilities CultivationLiabilities	11817000	USD
CY2020Q4	cweb	Cultivation Liabilities Current CultivationLiabilitiesCurrent	9304000	USD
CY2020Q4	cweb	Cultivation Liabilities Noncurrent CultivationLiabilitiesNoncurrent	2513000	USD
CY2020Q4	cweb	Cultivation Liabilities CultivationLiabilities	11817000	USD
CY2021	cweb	Cultivation Liability Settlement Payments Current CultivationLiabilitySettlementPaymentsCurrent	7166000	USD
CY2021	cweb	Cultivation Liability Settlement Payments Noncurrent CultivationLiabilitySettlementPaymentsNoncurrent	0	USD
CY2021	cweb	Cultivation Liability Settlement Payments CultivationLiabilitySettlementPayments	7166000	USD
CY2021	cweb	Cultivation Liability Settlement Reduction Current CultivationLiabilitySettlementReductionCurrent	855000	USD
CY2021	cweb	Cultivation Liability Settlement Reduction Noncurrent CultivationLiabilitySettlementReductionNoncurrent	0	USD
CY2021	cweb	Cultivation Liability Settlement Reduction CultivationLiabilitySettlementReduction	855000	USD
CY2021	cweb	Cultivation Liability Interest Expense Current CultivationLiabilityInterestExpenseCurrent	37000	USD
CY2021	cweb	Cultivation Liability Interest Expense Noncurrent CultivationLiabilityInterestExpenseNoncurrent	0	USD
CY2021	cweb	Cultivation Liability Interest Expense CultivationLiabilityInterestExpense	37000	USD
CY2021	cweb	Cultivation Liability Conversion To Short Term Borrowing Current CultivationLiabilityConversionToShortTermBorrowingCurrent	-2128000	USD
CY2021	cweb	Cultivation Liability Conversion To Short Term Borrowing Noncurrent CultivationLiabilityConversionToShortTermBorrowingNoncurrent	2128000	USD
CY2021	cweb	Cultivation Liability Conversion To Short Term Borrowing CultivationLiabilityConversionToShortTermBorrowing	0	USD
CY2021Q4	cweb	Cultivation Liabilities Current CultivationLiabilitiesCurrent	3448000	USD
CY2021Q4	cweb	Cultivation Liabilities Noncurrent CultivationLiabilitiesNoncurrent	385000	USD
CY2021Q4	cweb	Cultivation Liabilities CultivationLiabilities	3833000	USD
CY2021Q4	us-gaap	Contractual Obligation Due In Next Twelve Months ContractualObligationDueInNextTwelveMonths	3461000	USD
CY2021Q4	us-gaap	Contractual Obligation Due In Second Year ContractualObligationDueInSecondYear	385000	USD
CY2021Q4	us-gaap	Contractual Obligation ContractualObligation	3846000	USD
CY2021Q4	cweb	Contractual Obligation Undiscounted Excess Amount ContractualObligationUndiscountedExcessAmount	13000	USD
CY2021Q4	cweb	Cultivation Liabilities CultivationLiabilities	3833000	USD
CY2021Q4	cweb	Cultivation Liabilities Current CultivationLiabilitiesCurrent	3448000	USD
CY2021Q4	cweb	Cultivation Liabilities Noncurrent CultivationLiabilitiesNoncurrent	385000	USD
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	142335464	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	142335464	shares
CY2021Q4	cweb	Proportionate Voting Stock Shares Issued ProportionateVotingStockSharesIssued	0	shares
CY2021Q4	cweb	Proportionate Voting Stock Shares Outstanding ProportionateVotingStockSharesOutstanding	0	shares
CY2021Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2021Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2021	cweb	Proportionate Voting Stock Dividend Rights Common Stock Dividend Multiplier ProportionateVotingStockDividendRightsCommonStockDividendMultiplier	400
CY2021Q4	cweb	Common Stock Voting Rights Number Of Votes CommonStockVotingRightsNumberOfVotes	1	vote
CY2021Q4	cweb	Proportionate Voting Stock Shares Outstanding ProportionateVotingStockSharesOutstanding	0	shares
CY2021Q4	cweb	Proportionate Voting Stock Shares Issued ProportionateVotingStockSharesIssued	0	shares
CY2020Q4	cweb	Proportionate Voting Stock Shares Issued ProportionateVotingStockSharesIssued	81177	shares
CY2020Q4	cweb	Proportionate Voting Stock Shares Outstanding ProportionateVotingStockSharesOutstanding	81177	shares
CY2021	cweb	Proportionate Voting Stock Dividend Rights Common Stock Dividend Multiplier ProportionateVotingStockDividendRightsCommonStockDividendMultiplier	400
CY2021Q4	cweb	Proportionate Voting Stock Voting Rights Number Of Votes ProportionateVotingStockVotingRightsNumberOfVotes	400	vote
CY2021	cweb	Proportionate Voting Stock Conversion Ratio ProportionateVotingStockConversionRatio	400
CY2021	cweb	Proportionate Voting Stock Liquidation Preference Common Stock Amount Distributed Multiplier ProportionateVotingStockLiquidationPreferenceCommonStockAmountDistributedMultiplier	400
CY2021Q2	cweb	Sale Of Stock Maximum Value Of Shares Offered SaleOfStockMaximumValueOfSharesOffered	60000000	CAD
CY2021	us-gaap	Sale Of Stock Number Of Shares Issued In Transaction SaleOfStockNumberOfSharesIssuedInTransaction	4740300	shares
CY2021Q4	us-gaap	Sale Of Stock Price Per Share SaleOfStockPricePerShare	1.85
CY2021	cweb	Sale Of Stock Gross Consideration Received On Transaction SaleOfStockGrossConsiderationReceivedOnTransaction	8714000	USD
CY2021	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	596000	USD
CY2021	us-gaap	Sale Of Stock Consideration Received On Transaction SaleOfStockConsiderationReceivedOnTransaction	8118000	USD
CY2020Q2	us-gaap	Sale Of Stock Number Of Shares Issued In Transaction SaleOfStockNumberOfSharesIssuedInTransaction	10000000	shares
CY2020Q2	us-gaap	Sale Of Stock Price Per Share SaleOfStockPricePerShare	6.75
CY2020Q2	us-gaap	Sale Of Stock Price Per Share SaleOfStockPricePerShare	4.97
CY2020Q2	cweb	Sale Of Stock Gross Consideration Received On Transaction SaleOfStockGrossConsiderationReceivedOnTransaction	77625000000	CAD
CY2020Q2	cweb	Sale Of Stock Gross Consideration Received On Transaction SaleOfStockGrossConsiderationReceivedOnTransaction	57165000000	USD
CY2020Q2	cweb	Number Of Common Shares In Each Unit NumberOfCommonSharesInEachUnit	1	shares
CY2020Q2	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	8.50
CY2020Q2	us-gaap	Warrants And Rights Outstanding Term WarrantsAndRightsOutstandingTerm	P2Y
CY2020Q2	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	5750000	shares
CY2020Q2	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	9206000	USD
CY2020	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	3368000	USD
CY2020Q2	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	5750000	shares
CY2020Q2	cweb	Class Of Warrant Or Right Fair Market Value ClassOfWarrantOrRightFairMarketValue	1.601
CY2020Q2	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	9206000	USD
CY2020Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	10142872	shares
CY2020Q4	cweb	Class Of Warrant Or Right Outstanding Weighted Average Exercise Price ClassOfWarrantOrRightOutstandingWeightedAverageExercisePrice	8.80
CY2021	cweb	Class Of Warrant Or Right Exercised ClassOfWarrantOrRightExercised	98788	shares
CY2021	cweb	Class Of Warrant Or Right Exercised Weighted Average Exercise Price ClassOfWarrantOrRightExercisedWeightedAverageExercisePrice	4.42
CY2021	cweb	Class Of Warrant Or Right Expired ClassOfWarrantOrRightExpired	-3060944	shares
CY2021	cweb	Class Of Warrant Or Right Expired Weighted Average Exercise Price ClassOfWarrantOrRightExpiredWeightedAverageExercisePrice	10.94
CY2021Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	6983140	shares
CY2021Q4	cweb	Class Of Warrant Or Right Outstanding Weighted Average Exercise Price ClassOfWarrantOrRightOutstandingWeightedAverageExercisePrice	7.86
CY2021	cweb	Class Of Warrant Or Right Weighted Average Remaining Contractual Term ClassOfWarrantOrRightWeightedAverageRemainingContractualTerm	P0Y6M14D
CY2021	cweb	Proportionate Voting Stock Conversion Ratio ProportionateVotingStockConversionRatio	400
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-137722000	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-30681000	USD
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	140769247	shares
CY2020	cweb	Weighted Average Number Of Shares Outstanding Excluding Proportionate Voting Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingExcludingProportionateVotingSharesOutstandingBasic	88996249	shares
CY2021	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	0	shares
CY2020	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	0	shares
CY2021	cweb	Weighted Average Number Of Proportionate Voting Shares Outstanding Basic WeightedAverageNumberOfProportionateVotingSharesOutstandingBasic	0	shares
CY2020	cweb	Weighted Average Number Of Proportionate Voting Shares Outstanding Basic WeightedAverageNumberOfProportionateVotingSharesOutstandingBasic	90040	shares
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	140769247	shares
CY2020	cweb	Weighted Average Number Of Shares Outstanding Excluding Proportionate Voting Shares Outstanding Diluted WeightedAverageNumberOfSharesOutstandingExcludingProportionateVotingSharesOutstandingDiluted	88996249	shares
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P7Y6M14D
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant	8855118	shares
CY2021	cweb	Weighted Average Number Of Proportionate Voting Shares Outstanding Diluted WeightedAverageNumberOfProportionateVotingSharesOutstandingDiluted	0	shares
CY2020	cweb	Weighted Average Number Of Proportionate Voting Shares Outstanding Diluted WeightedAverageNumberOfProportionateVotingSharesOutstandingDiluted	90040	shares
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.98
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.98
CY2020	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.25
CY2020	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.25
CY2021	cweb	Earnings Per Proportionate Voting Share Basic EarningsPerProportionateVotingShareBasic	0
CY2021	cweb	Earnings Per Proportionate Voting Share Diluted EarningsPerProportionateVotingShareDiluted	0
CY2020	cweb	Earnings Per Proportionate Voting Share Diluted EarningsPerProportionateVotingShareDiluted	-98.17
CY2020	cweb	Earnings Per Proportionate Voting Share Basic EarningsPerProportionateVotingShareBasic	-98.17
CY2021	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	12143874000	shares
CY2020	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	13929753000	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized	13500000	shares
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P5Y6M14D
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum	0.820
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum	0.865
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum	0.841
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum	0.874
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum	0.013
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum	0.017
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum	0.005
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum	0.014
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	1039229	USD
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	2003375	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	2.56
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	3330206	shares
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	3.93
CY2020	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P7Y9M29D
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	4955658	USD
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	1290662	shares
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	3.56
CY2021	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	8261	shares
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	3.64
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	1268724	shares
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	5.57
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	3343883	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	3.16
CY2021Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	941729	USD
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P7Y6M14D
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	3.56
CY2020	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P7Y9M29D
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	4.92
CY2021	cweb	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Weighted Average Share Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageSharePrice	4.85
CY2020	cweb	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Weighted Average Share Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageSharePrice	5.20
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares	720261	shares
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue	5.93
CY2020	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares	1004939	shares
CY2020	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue	4.84
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	3343883	shares
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue	751000	USD
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	456675	shares
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	6.47
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	2160313	shares
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	2.50
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod	584290	shares
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue	5.07
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod	182727	shares
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue	5.40
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	1816851	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	2.28
CY2021	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	5483000	USD
CY2020	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	4326000	USD
CY2021Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	4638000	USD
CY2020Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	6769000	USD
CY2021	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	160000	USD
CY2020	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	7000	USD
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-137589000	USD
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-38793000	USD
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	10000	USD
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	98000	USD
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-137579000	USD
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-38695000	USD
CY2021	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	-50000	USD
CY2020	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	-8217000	USD
CY2021	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	33000	USD
CY2020	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	176000	USD
CY2021	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	143000	USD
CY2020	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	-8034000	USD
CY2021	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	0	USD
CY2020	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	0	USD
CY2021	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	0	USD
CY2020	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	0	USD
CY2021	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	0	USD
CY2020	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	20000	USD
CY2021	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	0	USD
CY2020	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	20000	USD
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	143000	USD
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-8014000	USD
CY2021	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210
CY2021	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210
CY2020	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210
CY2021	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.018
CY2020	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.047
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost	-0.003
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost	0.072
CY2021	cweb	Effective Income Tax Rate Reconciliation Nondeductible Expense Change In Fair Value Of Financial Instruments And Other Percent EffectiveIncomeTaxRateReconciliationNondeductibleExpenseChangeInFairValueOfFinancialInstrumentsAndOtherPercent	0.014
CY2020	cweb	Effective Income Tax Rate Reconciliation Nondeductible Expense Change In Fair Value Of Financial Instruments And Other Percent EffectiveIncomeTaxRateReconciliationNondeductibleExpenseChangeInFairValueOfFinancialInstrumentsAndOtherPercent	0.061
CY2021	cweb	Effective Income Tax Rate Reconciliation Nondeductible Expense Transaction Costs Percent EffectiveIncomeTaxRateReconciliationNondeductibleExpenseTransactionCostsPercent	0
CY2020	cweb	Effective Income Tax Rate Reconciliation Nondeductible Expense Transaction Costs Percent EffectiveIncomeTaxRateReconciliationNondeductibleExpenseTransactionCostsPercent	-0.021
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Impairment Losses EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses	-0.114
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Impairment Losses EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses	0
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.125
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.185
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits Research EffectiveIncomeTaxRateReconciliationTaxCreditsResearch	-0.004
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits Research EffectiveIncomeTaxRateReconciliationTaxCreditsResearch	-0.029
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	-0.005
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	-0.006
CY2021	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.001
CY2020	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.207
CY2020Q4	cweb	Income Tax Receivable Cares Act IncomeTaxReceivableCARESAct	8056000	USD
CY2021Q4	cweb	Income Tax Receivable Cares Act IncomeTaxReceivableCARESAct	8056000	USD
CY2020Q4	cweb	Income Tax Receivable Cares Act IncomeTaxReceivableCARESAct	8056000	USD
CY2021Q4	cweb	Income Tax Receivable Cares Act IncomeTaxReceivableCARESAct	8056000	USD
CY2020	cweb	Cares Act Income Tax Benefit Net Operating Loss Deferred Tax Asset CARESActIncomeTaxBenefitNetOperatingLossDeferredTaxAsset	6218000	USD
CY2020	cweb	Cares Act Income Tax Benefit Tax Rate Differential CARESActIncomeTaxBenefitTaxRateDifferential	1838000	USD
CY2019Q4	cweb	Income Tax Receivable Cares Act IncomeTaxReceivableCARESAct	3273000	USD
CY2020Q4	us-gaap	Income Tax Receivable IncomeTaxReceivable	11440000	USD
CY2021	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	676000	USD
CY2021Q4	cweb	Deferred Tax Assets Operating Loss And Other Loss Carryforwards DeferredTaxAssetsOperatingLossAndOtherLossCarryforwards	45557000	USD
CY2020Q4	cweb	Deferred Tax Assets Operating Loss And Other Loss Carryforwards DeferredTaxAssetsOperatingLossAndOtherLossCarryforwards	33961000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	1853000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	1717000	USD
CY2021Q4	cweb	Deferred Tax Assets Inventory And Unicap263 A DeferredTaxAssetsInventoryAndUNICAP263A	4191000	USD
CY2020Q4	cweb	Deferred Tax Assets Inventory And Unicap263 A DeferredTaxAssetsInventoryAndUNICAP263A	4653000	USD
CY2021Q4	cweb	Deferred Tax Assets Lease Liability DeferredTaxAssetsLeaseLiability	5586000	USD
CY2020Q4	cweb	Deferred Tax Assets Lease Liability DeferredTaxAssetsLeaseLiability	5455000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	385000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	1186000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	121000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	0	USD
CY2021Q4	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	514000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	0	USD
CY2021Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	58207000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	46972000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	52888000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	35685000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	5319000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	11287000	USD
CY2021Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	0	USD
CY2020Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	851000	USD
CY2021Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets	0	USD
CY2020Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets	5127000	USD
CY2021Q4	us-gaap	Deferred Tax Liabilities Leasing Arrangements DeferredTaxLiabilitiesLeasingArrangements	5110000	USD
CY2020Q4	us-gaap	Deferred Tax Liabilities Leasing Arrangements DeferredTaxLiabilitiesLeasingArrangements	5103000	USD
CY2021Q4	cweb	Deferred Tax Liabilities Warrants DeferredTaxLiabilitiesWarrants	209000	USD
CY2020Q4	cweb	Deferred Tax Liabilities Warrants DeferredTaxLiabilitiesWarrants	206000	USD
CY2021Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	5319000	USD
CY2020Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	11287000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	0	USD
CY2020Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	0	USD
CY2021	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	17203000	USD
CY2020	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	11251000	USD
CY2021Q4	cweb	Net Operating Loss Carryforwards Not Subject To Expiration NetOperatingLossCarryforwardsNotSubjectToExpiration	170443000	USD
CY2021Q4	cweb	Net Operating Loss Carryforwards Subject To Expiration NetOperatingLossCarryforwardsSubjectToExpiration	144225000	USD
CY2021Q4	us-gaap	Tax Credit Carryforward Amount TaxCreditCarryforwardAmount	1788000	USD
CY2020Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	134000	USD
CY2021	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	52000	USD
CY2021	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	0	USD
CY2021	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	7000	USD
CY2021	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Settlements With Taxing Authorities UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities	0	USD
CY2021Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	179000	USD
CY2019Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	USD
CY2020	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	55000	USD
CY2020	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	79000	USD
CY2020	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	0	USD
CY2020	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Settlements With Taxing Authorities UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities	0	USD
CY2020Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	134000	USD
CY2021Q4	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	0	USD
CY2020Q4	us-gaap	Notes Receivable Related Parties NotesReceivableRelatedParties	1000000000	USD
CY2020Q4	us-gaap	Related Party Transaction Rate RelatedPartyTransactionRate	0.0325
CY2021Q4	us-gaap	Notes Receivable Related Parties NotesReceivableRelatedParties	1037000	USD
CY2021Q1	cweb	Payment For Business Combination Purchase Option PaymentForBusinessCombinationPurchaseOption	8000	USD
CY2021Q2	cweb	Business Combination Purchase Option Extended Term BusinessCombinationPurchaseOptionExtendedTerm	P1Y

Files In Submission

Name	View Source	Status
0001750155-22-000041-index-headers.html	Edgar Link	pending
0001750155-22-000041-index.html	Edgar Link	pending
0001750155-22-000041.txt	Edgar Link	pending
0001750155-22-000041-xbrl.zip	Edgar Link	pending
cweb-20211231.htm	Edgar Link	pending
cweb-20211231.xsd	Edgar Link	pending
cweb-20211231_cal.xml	Edgar Link	unprocessable
cweb-20211231_def.xml	Edgar Link	unprocessable
cweb-20211231_htm.xml	Edgar Link	completed
cweb-20211231_lab.xml	Edgar Link	unprocessable
cweb-20211231_pre.xml	Edgar Link	unprocessable
ex1035.htm	Edgar Link	pending
ex1036.htm	Edgar Link	pending
ex211.htm	Edgar Link	pending
ex231.htm	Edgar Link	pending
ex311.htm	Edgar Link	pending
ex312.htm	Edgar Link	pending
ex321.htm	Edgar Link	pending
ex322.htm	Edgar Link	pending
ex43.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$CWBHF
Stock $cwbhf

2021 Q4 Form 10-K Financial Statement

#000175015522000041 Filed on March 24, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CWBHF Stock $cwbhf

2021 Q4 Form 10-K Financial Statement

#000175015522000041 Filed on March 24, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CWBHF
Stock $cwbhf